{"transactions":[{"id":1485284,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T23:44:44.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":123818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on June 6, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":123818,"derivative":{"exercise_price":17,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":123818},"source":{"system":"sec-edgar","filing":"0000950170-24-071541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000095017024071541/ownership.xml","form_type":"4"}},{"id":2341593,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":45499,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the terms of the Merger Agreement, each restricted stock unit (including performance stock units) was canceled and converted into the right to receive an amount in cash equal to (i) the product of (A) the total number of Shares subject to (or deliverable under) such restricted stock unit (with any performance conditions deemed achieved at maximum levels with respect to any performance stock unit) multiplied by (B) the Cash Amount, and (ii) one CVR with respect to each Share subject to such restricted stock unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":45499},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341592,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":18.76,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341591,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":39000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":27.36,"expiration_date":"2030-03-03","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341590,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":10.2,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341589,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":10.35,"expiration_date":"2026-03-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341588,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":28500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":13.32,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341587,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":28125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":10.64,"expiration_date":"2025-03-16","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341586,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":16.64,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341585,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":53125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":24.16,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":53125},"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2341584,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-09T19:08:18.000Z","date":"2022-03-07","kind":"other","acquired":false,"shares":25022,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 18, 2022, (the \"Merger Agreement\"), among UCB S.A., a societe anonyme formed under the laws of Belgium (\"Parent\"), Zinc Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (\"Purchaser\") and the Issuer, pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 7, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was canceled and converted into the right to receive $26.00 in cash (the \"Cash Amount\") plus a contingent value right (\"CVR\"), which CVR represents the right to receive a contingent payment of $2.00 which amount will become payable, if at all, if a specified milestone is achieved on or prior to December 31, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 3,219 Shares (as defined below) acquired under the Issuer's Employee Stock Purchase Plan since the last filing by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 18, 2022, (the \"Merger Agreement\"), among UCB S.A., a societe anonyme formed under the laws of Belgium (\"Parent\"), Zinc Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (\"Purchaser\") and the Issuer, pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 7, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was canceled and converted into the right to receive $26.00 in cash (the \"Cash Amount\") plus a contingent value right (\"CVR\"), which CVR represents the right to receive a contingent payment of $2.00 which amount will become payable, if at all, if a specified milestone is achieved on or prior to December 31, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-010297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010297/doc4.xml","form_type":"4"}},{"id":2606745,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-11T21:22:26.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ZGNX common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vests in four equal installments on each of August 5, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001375151-21-000087","document":"wf-form4_162873132359247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000087/wf-form4_162873132359247.xml","form_type":"4"}},{"id":2767862,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-30T21:26:39.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ZGNX common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vests in four equal installments on each of March 15, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001375151-21-000041","document":"wf-form4_161715398397913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000041/wf-form4_161715398397913.xml","form_type":"4"}},{"id":2767861,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-30T21:26:39.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments, with the first vest date occurring on April 15, 2021, subject to the reporting person's continued service to the Company on the applicable vesting dates."}],"balance_after":30000,"derivative":{"exercise_price":18.76,"expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001375151-21-000041","document":"wf-form4_161715398397913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000041/wf-form4_161715398397913.xml","form_type":"4"}},{"id":2781793,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The restricted stock units vests in four equal installments on each of March 15, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Not applicable."}],"balance_after":4875,"derivative":{"underlying":"Common Stock","underlying_shares":1625},"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781792,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":2031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The restricted stock units vests in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Not applicable."}],"balance_after":4062,"derivative":{"underlying":"Common Stock","underlying_shares":2031},"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781791,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The restricted stock units vests in four equal installments on each of March 15, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Not applicable."}],"balance_after":1562,"derivative":{"underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781790,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":455,"price":20.7,"value":9418.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 6."}],"balance_after":21803,"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781789,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 4, 2020."}],"balance_after":22258,"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781788,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":569,"price":20.7,"value":11778.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 4."}],"balance_after":20633,"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781787,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":2031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 22, 2019."}],"balance_after":21202,"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781786,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":438,"price":20.7,"value":9066.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 1."}],"balance_after":19171,"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":2781785,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:04:20.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 845 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":19609,"source":{"system":"sec-edgar","filing":"0001375151-21-000023","document":"wf-form4_161601144117165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000023/wf-form4_161601144117165.xml","form_type":"4"}},{"id":3097480,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-29T21:53:20.000Z","date":"2020-06-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (RSUs) were granted on March 14, 2017, with 100% of the RSUs to vest upon approval of the Company's New Drug Application (NDA) by the U.S. Food and Drug Administration for Fintepla. The NDA was approved on June 25, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001375151-20-000115","document":"wf-form4_159348195885012.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000115/wf-form4_159348195885012.xml","form_type":"4"}},{"id":3097479,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:53:20.000Z","date":"2020-06-25","kind":"tax_withholding","acquired":false,"shares":2813,"price":28.12,"value":79101.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of RSUs described in footnote 1."}],"balance_after":17202,"source":{"system":"sec-edgar","filing":"0001375151-20-000115","document":"wf-form4_159348195885012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000115/wf-form4_159348195885012.xml","form_type":"4"}},{"id":3097478,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:53:20.000Z","date":"2020-06-25","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted on March 14, 2017, with 100% of the RSUs to vest upon approval of the Company's New Drug Application (NDA) by the U.S. Food and Drug Administration for Fintepla. The NDA was approved on June 25, 2020."}],"balance_after":20015,"source":{"system":"sec-edgar","filing":"0001375151-20-000115","document":"wf-form4_159348195885012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000115/wf-form4_159348195885012.xml","form_type":"4"}},{"id":3199209,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-20T16:01:02.000Z","date":"2020-03-18","kind":"purchase","acquired":true,"shares":1000,"price":19.685,"value":19685.0,"ownership":{"direct":true},"balance_after":10015,"source":{"system":"sec-edgar","filing":"0001375151-20-000045","document":"wf-form4_158473444472517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000045/wf-form4_158473444472517.xml","form_type":"4"}},{"id":3204904,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-17T19:25:13.000Z","date":"2020-03-15","kind":"exercise","acquired":false,"shares":2032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The restricted stock units vests in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Not applicable."}],"balance_after":6093,"derivative":{"underlying":"Common Stock","underlying_shares":2032},"source":{"system":"sec-edgar","filing":"0001375151-20-000036","document":"wf-form4_158448749638888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000036/wf-form4_158448749638888.xml","form_type":"4"}},{"id":3204903,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-17T19:25:13.000Z","date":"2020-03-15","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vests in four equal installments on each of March 15, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Not applicable."}],"balance_after":3124,"derivative":{"underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001375151-20-000036","document":"wf-form4_158448749638888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000036/wf-form4_158448749638888.xml","form_type":"4"}},{"id":3204902,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:25:13.000Z","date":"2020-03-15","kind":"tax_withholding","acquired":false,"shares":558,"price":22.01,"value":12281.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 4."}],"balance_after":9015,"source":{"system":"sec-edgar","filing":"0001375151-20-000036","document":"wf-form4_158448749638888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000036/wf-form4_158448749638888.xml","form_type":"4"}},{"id":3204901,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:25:13.000Z","date":"2020-03-15","kind":"exercise","acquired":true,"shares":2032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 22, 2019."}],"balance_after":9573,"source":{"system":"sec-edgar","filing":"0001375151-20-000036","document":"wf-form4_158448749638888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000036/wf-form4_158448749638888.xml","form_type":"4"}},{"id":3204900,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:25:13.000Z","date":"2020-03-15","kind":"tax_withholding","acquired":false,"shares":429,"price":22.01,"value":9442.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 1."}],"balance_after":7541,"source":{"system":"sec-edgar","filing":"0001375151-20-000036","document":"wf-form4_158448749638888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000036/wf-form4_158448749638888.xml","form_type":"4"}},{"id":3204899,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:25:13.000Z","date":"2020-03-15","kind":"exercise","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 624 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":7970,"source":{"system":"sec-edgar","filing":"0001375151-20-000036","document":"wf-form4_158448749638888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000036/wf-form4_158448749638888.xml","form_type":"4"}},{"id":3222414,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-06T16:09:13.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal installments on each of March 15, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":6500,"derivative":{"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001375151-20-000024","document":"wf-form4_158352893555261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000024/wf-form4_158352893555261.xml","form_type":"4"}},{"id":3222413,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T16:09:13.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2020, subject to the reporting person's continuous service to the Company on the applicable vesting dates."}],"balance_after":39000,"derivative":{"exercise_price":27.36,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001375151-20-000024","document":"wf-form4_158352893555261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000024/wf-form4_158352893555261.xml","form_type":"4"}},{"id":3578317,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-26T16:12:56.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vests in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":8125,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001375151-19-000044","document":"wf-form4_155363116167820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000044/wf-form4_155363116167820.xml","form_type":"4"}},{"id":3578316,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-26T16:12:56.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":63750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2019, subject to the reporting person's continuous service to the Company on the applicable vesting dates."}],"balance_after":63750,"derivative":{"exercise_price":52.66,"expiration_date":"2029-03-22","underlying":"Common Stock","underlying_shares":63750},"source":{"system":"sec-edgar","filing":"0001375151-19-000044","document":"wf-form4_155363116167820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000044/wf-form4_155363116167820.xml","form_type":"4"}},{"id":3586334,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-19T19:00:45.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ZGNX common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":4687,"derivative":{"underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001375151-19-000035","document":"wf-form4_155303642979821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000035/wf-form4_155303642979821.xml","form_type":"4"}},{"id":3586333,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-19T19:00:45.000Z","date":"2019-03-15","kind":"tax_withholding","acquired":false,"shares":429,"price":51.88,"value":22256.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units granted to the Reporting Person."}],"balance_after":5783,"source":{"system":"sec-edgar","filing":"0001375151-19-000035","document":"wf-form4_155303642979821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000035/wf-form4_155303642979821.xml","form_type":"4"}},{"id":3586332,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-19T19:00:45.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 616 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":6212,"source":{"system":"sec-edgar","filing":"0001375151-19-000035","document":"wf-form4_155303642979821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000035/wf-form4_155303642979821.xml","form_type":"4"}},{"id":3992197,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-16T16:17:50.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest as to 1/4th of the original number of shares subject to the restricted stock unit award on the one-year anniversary of the date of grant, and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each of the following three anniversaries, subject to the reporting person's continued service with the Issuer on the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001375151-18-000018","document":"wf-form4_152123145655120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000018/wf-form4_152123145655120.xml","form_type":"4"}},{"id":3992196,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-16T16:17:50.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2018, subject to the reporting person's continued service with the Issuer on the applicable vesting dates."}],"balance_after":37500,"derivative":{"exercise_price":42.65,"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001375151-18-000018","document":"wf-form4_152123145655120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000018/wf-form4_152123145655120.xml","form_type":"4"}},{"id":4130197,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-15T16:26:01.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":1346,"price":36.5859,"value":49244.6214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.55 to $36.65, inclusive. The Reporting Person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares purchased under the company's employee stock purchase plan which were not previously reported pursuant to the exemption under Rule 16b-3(c)."}],"balance_after":4033,"source":{"system":"sec-edgar","filing":"0000899243-17-028862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924317028862/doc4.xml","form_type":"4"}},{"id":4382235,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-16T20:00:41.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ZGNX common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest upon the approval by the U.S. Food and Drug Administration of the Company's New Drug Application for ZX008, provided such approval occurs within five years following the grant date, subject to the option recipient's continuous service to the Company on such vesting date."}],"balance_after":10000,"derivative":{"expiration_date":"2022-03-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-17-007841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924317007841/doc4.xml","form_type":"4"}},{"id":4382234,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":90108,"kind":"person","name":"Galer Bradley S.","position":1,"cik":"0001594565","reported_name":"Galer Bradley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-16T20:00:41.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on March 14, 2017 and vests in a series of forty-eight (48) successive, equal monthly installments beginning on April 14, 2017, subject to the reporting person's continued employment with the Company on each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":10.2,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-17-007841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924317007841/doc4.xml","form_type":"4"}}]}